STAMFORD, CT — Curaleaf at 814 E. Main St., in Stamford will begin recreational cannabis sales at 10 a.m., on Saturday, Jan. 28, just days after the Stamford Zoning Board granted approval for hybrid use by a vote of 3-2.
The location opened as a medical marijuana dispensary in 2019, and has operated under Curaleaf since 2020.
Curaleaf is a leading international provider of consumer cannabis products. The Stamford location is the company’s first dispensary in the state to open its doors to adult-use customers.
There are Curaleaf medical dispensaries in Hartford, Milford and Groton. The company anticipates welcoming adult-use customers at additional locations in the near future, pending regulatory approvals.
As part of the approval from Stamford, hybrid sales will be conducted through an online ordering platform for the first four weeks. Patch reached out to Curaleaf for more information on when the online recreational ordering platform will go live.
Interested in local real estate?Subscribe to Patch’s new newsletter to be the first to know about open houses, new listings and more.
To celebrate on Saturday, festivities throughout the day will include vendor-sponsored giveaways, product discounts, music and complimentary food and drinks.
The dispensary’s wide array of cannabis goods includes Curaleaf whole flower, pre-rolls, edibles, topicals, tinctures, vape products and Curaleaf’s breakthrough vape hardware, Cliq by Select.
“Curaleaf is proud to be a part of Connecticut’s rapidly expanding adult-use market,” said Matt Darin, CEO of Curaleaf, in a news release. “As we welcome new adult-use customers, I want to assure our medical patients that they will continue to be prioritized and receive the high quality of care they are accustomed to.”
Luke Flood, Curaleaf’s vice president of real estate, said in an emailed statement to Patch this week that the Stamford dispensary will add new point-of-sale terminals and will make some adjustments to the floor layout “for a smoother customer flow.”
Medical patients will have priority access into the dispensary through a separate entrance, experience quicker check-ins with a dedicated staff, and will have a separate line for check-out.
In addition, medical patients will continue to have access to Curaleaf’s Compassionate Care Plan, the dispensary’s pharmacy team and patient consult rooms.
The two zoning board members who opposed the change of use said they had concerns about impacts to traffic in the area.
The approval was granted with several conditions, notably that Curaleaf will have to submit a revised traffic study using data collected approximately 30 days after beginning recreational sales.
The scope will cover all intersections within 650 feet of the facility. If the study shows significant impacts to the roadway network, Curaleaf will be responsible for the cost of mitigation measures determined by the city.
Curaleaf will be open from 10 a.m., to 8 p.m., Monday through Saturday, and 10 a.m., to 7 p.m., on Sunday.
Curaleaf now joins Fine Fettle, a hybrid dispensary at 12 Research Drive in the Glenbrook section of Stamford, which began hybrid sales on Jan. 10.